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Abstract
Background: Arsenic is a known human carcinogen reported to cause chromosomal deletions and genetic
anomalies in cultured cells. The vast human population inhabiting the Ganges delta in West Bengal, India and
Bangladesh is exposed to critical levels of arsenic present in the groundwater. The genetic and physiological
mechanism of arsenic toxicity in the human body is yet to be fully established. In addition, lack of animal models
has made work on this line even more challenging.
Methods: Human male blood samples were collected with their informed consent from 5 districts in West Bengal
having groundwater arsenic level more than 50 μg/L. Isolation of genomic DNA and preparation of metaphase
chromosomes was done using standard protocols. End point PCR was performed for established sequence tagged
sites to ascertain the status of recombination events. Single nucleotide variants of candidate genes and amplicons
were carried out using appropriate restriction enzymes. The copy number of DYZ1 array per haploid genome was
calculated using real time PCR and its chromosomal localization was done by fluorescence in-situ hybridization
(FISH).
Results: We studied effects of arsenic exposure on the human Y chromosome in males from different areas of
West Bengal focusing on known recombination events (P5-P1 proximal; P5-P1 distal; gr/gr; TSPY-TSPY, b1/b3 and
b2/b3), single nucleotide variants (SNVs) of a few candidate Y-linked genes (DAZ, TTY4, BPY2, GOLGA2LY) and the
amplicons of AZFc region. Also, possible chromosomal reorganization of DYZ1 repeat arrays was analyzed. Barring
a few microdeletions, no major changes were detected in blood DNA samples. SNV analysis showed a difference in
some alleles. Similarly, DYZ1 arrays signals detected by FISH were found to be affected in some males.
Conclusions: Our Y chromosome analysis suggests that the same is protected from the effects of arsenic by some
unknown mechanisms maintaining its structural and functional integrities. Thus, arsenic effects on the human body
seem to be different compared to that on the cultured cells.
Background
Several heavy metals are present in the environment all
over the world in amounts alarmingly unsafe for the
human population of which chromium and arsenic are
good examples. These metals affect human systems in
various ways but their possible genetic consequences
remain unknown. In the context of arsenic, Ganges
delta in West Bengal, India and Bangladesh, both area-
and population wise are the worlds most affected
regions. In Bangladesh, over 60% of villages are at the
risk from arsenic exposure [1].
Arsenic in the environment exists naturally in two
forms; as arsenite (trivalent As
3+) or arsenate (pentava-
lent As
5+). Humans are exposed to arsenic by ingestion
of contaminated water, food and drugs or inhalation
from burning of arsenic contaminated coal. Inhalation is
also contributed by semiconductor and glass manufac-
turing sites. Arsenic is present in small to trace amounts
in rocks, sediments and all natural water resources
which includes rivers, sea water and groundwater. In the
absence of treatment process, high levels of arsenic
become a major health hazards. The World Health
Organization (WHO) recommends less than 10 μg/L
arsenic in drinking water and its maximum permissible
limit is 50 μg/L [2]. Our present understanding of the
metal demands the limit to be set at 10 μg/L but the
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tions in countries with this problem makes them adhere
to a high permissible limit. The sensitivity of the sce-
nario may be judged by the fact that at consumption of
al i t e ro fw a t e rp e rd a yw i t h5 0μg/L arsenic, 13 per
thousand individuals may die due to liver, lung, kidney
or bladder cancer [3]. The risk is only reduced to about
37 per 10000 individuals at a level of 10 μg/L which is
the lowest of the enacted guidelines across the world
[4]. Besides, lesser exposed males are apparently more
prone to developing skin lesions as compared to females
with far greater exposure. Interestingly both sexes were
maximally affected at the same age group of 35-44 years
[5].
Arsenite despite being an established human carcino-
gen, its mechanism of carcinogenesis and genetic effects
remain unclear. What is known is that it induces chro-
mosomal aberrations in both human and rodent cell
lines and the cells of exposed humans [6-9]. Subse-
quently, these genetic abnormalities become cause of
cancer [10] though their random nature remains to be
explained. In addition, its role as a tumor promoter [11]
has been suggested without any direct evidence. Another
possibility includes its action as a co-mutagen by inter-
fering with DNA repair mechanism, enhancing the effect
of mutagens like UV and MNU (N-methyl-N-nitro-
sourea) [12]. The greatest challenge in understanding
arsenic carcinogenicity and its role in-vivo has been the
absence of animal models since it fails to replicate its
effect in rodents [13]. In addition the complexities seem
to be increasing from risk of erectile dysfunction in
exposed males [14] to its high levels in milk of lactating
mothers [15]. Also, estrogen sensitive targets may be
responsible for the differential affect in males and
females [16]. Most affected regions in India are the 9
districts in West Bengal where the recorded ground-
water arsenic level is more than 50 μg/L to which over
40 million people are exposed [17]. We collected human
blood samples from these districts and analyzed them
for anomalies, if any, focusing on their Y chromosomes.
Methods
Collection of blood samples and genomic DNA isolation
Blood samples (10 ml) were collected with informed
consent from 98 males from different areas of West
Bengal strictly in accordance with the Guidelines of
Institutes Ethical and Bio-safety Committee. The regions
were selected for having ground water arsenic of more
than 50 μg/L as reported earlier [17]. Present study
includes samples from 5 districts which include Kolkata,
Mednipur, Murshidabad, Maldah and 24 Paragnas (S).
The samples in the age group of 7 to 62 years were
s h o r tl i s t e db yc o n f i r m i n gt h a tt h e yw e r ec o n s u m i n g
ground water as such, without any treatment and were
exposed to arsenic for a minimum period of 7 years.
From these, 4 individuals (2k10, 2k28, 2k66 and MC7)
had skin lesions on faces or hands due to arsenic expo-
sure. Two persons (2k11 and 2k29) had been operated
for prostate enlargement. Also, routine blood analysis
for cell counts and hemoglobin level was done and only
the ones found to be normal were included in the study.
In addition blood was collected from 80 males residing
in New Delhi without any arsenic exposure and used as
controls. Genomic DNA isolation was done from blood
using standard protocols [18].
Sequence-tagged site PCR amplification
STS spanning all the known regions of Y chromosome
showing recombination deletions were amplified using
end point PCR. These included P5-proximal P1, P5- dis-
tal P1, gr/gr, b1/b3 and b2/b3 deletion. Screening was
d o n ef o rd e l e t i o no fe n t i r eA Z F ao rA Z F cr e g i o n .
Recombination events known to occur in AZFa due to
the presence of provirus A and B sequences were
checked. The AZFb region was analyzed for its intact-
ness using STS markers.
End point PCR analysis
The reactions in 20 μlv o l u m ew e r ec a r r i e do u tu s i n g
Go Taq polymerase and 5× reaction buffer (Promega,
Madison, USA), 200 μM dNTPs and 100 ng of template
DNA. The reaction was conducted for 30 cycles, each
involving denaturation at 95°C for 1 minute, annealing
at 60°C for 1 minute and extension at 72°C for 1 minute
besides initial denaturation at 95°C for 5 minutes and
final extension at 72°C for 10 minutes. The amplified
products were resolved on appropriate agarose gels. b-
actin and SRY primers were used as positive controls
[19].
Single Nucleotide Variants (SNV) analysis
For the analysis of SNVs initial PCR amplification was
carried out as above in 50 μl reaction mixture. After
subsequent confirmation of amplification, PCR product
was purified by adding 5 μl of 3 M sodium acetate and
150 μl of absolute ethanol which was then incubated at
-70°C for 2 hours. Thereafter, it was pelleted (13 k rpm
for 20 minutes) and washed with 70% ethanol before
dissolving and putting up for digestion with appropriate
restriction enzymes.
Real time PCR analysis of DYZ1 region
Genomic DNA from different samples was used as tem-
plate for analysis of number of DYZ1 arrays using Real
Time PCR. Power SYBR® green (Part No. 4367659) from
Applied Biosystems (ABI, USA). Reactions were carried
out on Sequence Detection System 7500 (ABI, USA).
Ten fold serial dilutions of the cloned DYZ1 plasmid
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standard curve preparation. The genomic DNA was
used in 3 different concentrations 2 ng, 1 ng and 0.5
ng and subsequently copies were calculated per gen-
ome for each sample. All the reactions were carried
out in triplicates. All the standard curves used had a
slope value of 3.3-3.5 and R
2 value of >0.99.
Fluorescence in situ hybridization (FISH)
Approximately, 300 μl of freshly collected blood from
both set of samples was cultured in PB Max karyotyp-
ing medium (GIBCO) and chromosome preparation
was done using standard protocols [20]. A 3.4 Kb
clone of the DYZ1 was labeled with biotin-dUTP using
Nick Translation Kit from Vysis (IL, USA) and used
for FISH following standard protocols [20]. The images
were analyzed by Applied Imaging Systems Cytovision
software version 3.92.
Results
Overall STS analysis for recombination events and
chromosome intactness
Samples were checked for the presence of STSs
encompassing recombination events and intactness of
the azoospermia factor (AZF) regions.
AZFc region
The AZFc region was analyzed for its intactness and
occurrence of different recombination events (P5-P1
proximal; P5-P1 distal; gr/gr; b1/b3 and b2/b3) as per
the details given in table 1[21-30]. Besides, the TSPY-
TSPY recombination was also accounted for (sY1240,
sY1250 positive and sY276, sY1238, sY637, sY1319 all
negative). None of the samples showed any of these
described recombination events. However, there were
random microdeletions in some samples. Results on
STS mapping of representative samples are shown in
figure 1.
AZFa region
T h ep r e s e n c eo fA Z F ar e g i o nw a sa s c e r t a i n e db ys t a n -
dard STS mapping involving six STSs sY78, sY1251,
sY1317, sY1316, sY1234 and sY1231. The absence of
sY1317, sY1316, and sY1234 has been taken to be indi-
cative of AZFa deletion. We did not find absence of
any of these STSs instead all of them were intact (Fig-
ure 1). Further, the region having HERV provirus
sequences was checked for homologous recombination
following standard markers [27] and the results are
g i v e ni nF i g u r e2 .N os a m p l eh a dt h ec h a r a c t e r i s t i c
provirus A or B mediated recombination. However,
several microdeletions mostly confined to the provirus
B region were detected.
AZFb region
The AZFb region was analyzed by multiplex PCR using
standard protocol [26]. It involved the screening of 10
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Page 3 of 12STSs including sY86, DFFRY, DDX3Y, sY95, sY117,
sY125, sY127, sY254, sY255 and RBMY STSs (Accession
no. G73375). All the samples were found to be positive
for these STSs (see figure 3a-c) indicating the intactness
of AZFb region.
SNV/SFV analysis
After the recombination analysis, we ascertained the
intactness of gene copies and amplicons by single
nucleotide variants (SNVs) in the AZFc region. We ana-
lyzed 7SNVs in DAZ gene, one each in BPY2, TTY4
and GOLGA2LY genes and 7 located in different ampli-
cons (b2, b3, b4, g1, g2, g3 and Gr)
DAZ SNVs
The samples were analyzed for reported SNVs in DAZ
gene which included DAZ SNV I to VI [31] and sY581
[32]. The amplicons were studied by end point PCR
amplification followed by digestion by corresponding
restriction enzymes (table 2). The DAZ deletions were
ascertained following standard method [28] that
showed intactness of the copies of DAZ gene. One
sample 2k44 showed deletion in the DAZ4 gene (DAZ
del. haplotype 4).
Amplicons
Further, we checked the SNVs in the blue, green and Gr
amplicons in the AZFc region following standard proto-
col [33] to establish their correlations with the normal
functioning of the Y chromosome. Representative gel
pictures for the same are shown in figure 3d-g. The
details of expected fragment pattern are given in table 2
and results summarized in table 3 and figure 4.
Other AZFc genes
We analyzed the SNV variants of BPY2, TTY4 and
GOLGA2LY genes on the Y chromosome. Few samples
showed allelic variations (Figure 3h-i) which have been
summarized in table 4.
DYZ1 array
The DYZ1 repeats on the human Y chromosome have
long been contemplated for their transcriptional status
Figure 1 Screening of STSs across the Y chromosome. Diagrammatic representation summarizing STS analysis in the representative samples
for screening of recombinations in the MSY region of the Y chromosome. We used 37 STSs to screen for different recombination deletions
including P5-Proximal P1, P5-Distal P1, gr/gr, b1/b3, b2/b3, TSPY-TSPY besides checking for the presence of AZFa region. sY14 located in SRY
gene was used as positive control. The sample IDs are given on the left side while the STSs analyzed are on top. Continuous blue line is
indicative of intactness of the STSs screened while the interrupting orange bars reflect absence of the same.
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[34,35]. We studied its overall intactness and copy num-
ber variation in the exposed males.
Intactness by end point PCR
For studying DYZ1 intactness, we designed 4 sets of pri-
mers spanning the entire 3.4 kb array. These primers
were then used in 10 different combinations for end
point PCR amplification. The details of the primers
used, their locations, different combinations and
expected amplicons are shown in tables 5 and 6. As per
this analysis all the samples (normal and exposed)
showed an intact DYZ1 array. The representative pic-
tures related to this analysis are shown in figure 5.
Assessment of Copy number variation of DYZ1 by real time
PCR
We checked number of DYZ1 copies per genome on
real time PCR using SYBR green chemistry. Cloned
DYZ1 array was used to prepare standard curve by ten-
fold serial dilutions starting from 30 crore to 300 copies.
The copies per genome in samples were subsequently
extrapolated from the standard curve. A representative
standard curve along with its amplification plots and
Figure 2 STS analysis of AZFa region. An illustration summarizing the result in representative samples for screening of recombination due to
HERV provirus sequences in the AZFa region. The green and red bars are the location of homologous sequences responsible for recombination.
Intact line indicates presence of STSs while dotted line reflects the corresponding deletion. Normal represents person without any recombination
event happening; RA represents deletion pattern expected due to recombination of sequences of the green bar while RB represents pattern due
to that of red bar. The STSs are given on top while sample IDs are given on left.
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samples from arsenic exposed areas showed a very high
degree of copy number variation ranging from 672
(sample 2k48) to 8576 (sample 2k21). Variation in the
unexposed samples was found to be within a lower 3910
to 4200 range. The distribution of variations in copy
number across the samples has been summarized in fig-
ure 6d.
FISH analysis
We used the 3.4 kb clone of DYZ1 array as FISH probe
for its chromosomal localization. The signals showed
two significant aspects. First, a consistent variation was
found in the signal intensity amongst nuclei of the same
individual. Secondly, in 19 exposed samples about (20-
25%) cells showed no signal. The remaining individuals
had signals in >98% cells. To rule out experimental
error, a positive control (individual already tested for
consistent signals) was used with the same probe
preparation. The experiment was replicated several
times and each time around 400 nuclei was screened.
Representative captured images of one of the samples
are shown in figure 7 highlighting these observations.
All the cells in the normal control samples showed con-
sistent DYZ1 signals. Also, to ascertain the presence of
Y chromosome, WCP-Y spectrum green (Cat no. 32-
122024) was purchased from VYSIS (Illinois, USA) and
used as reported earlier [36]. It showed signals in >96%
nuclei of all the individuals. Analysis of nuclei with spe-
cific probes for different regions of DYZ1 array is
underway.
Discussion
Arsenic is a known source of human carcinogen though
the mechanism of its carcinogenesis is still not clear.
The metabolism of arsenic involves methylation steps
subsequent to which monomethylarsanous acid (MMA)
Figure 3 Multiplex PCR for intactness of AZFb region and SNV analysis in the amplicons and genes. a-c shows representative gel
pictures of multiples PCR used for checking the intactness of AZFb region. The sample IDs are shown on top while the amplicon size along
with the corresponding STSs is given on right. None of the samples showed any deletion in this region for the STSs screened. d-g are the
results of representative samples for g, g1, g2 and g3 SFVs respectively. h-i represents SNV results for selective samples for TTY4 and BPY2,
respectively. For fragment length, restriction enzymes and other details refer to table 2.
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mammals [37]. It was long believed that the methylation
steps constitute a yet to be elucidated detoxification
process. However, the fact that bacteria and fungi can
successfully survive arsenic exposure and demethylate
the arsenic suggests that the methylation is an effect of
arsenic [38,39]. Further, mice have been found to be
highly resistant to arsenic toxicity. Though C3 H and
CD1 mice show increased liver tumor incidence exposed
to drinking water arsenic [40-43], it has yet to be con-
firmed. This is because subsequent experiments on C3
H mice by Ahlborn et al 2009 [44] reported a significant
reduction in tumor occurrence (0%) and also that the
arsenic exposure given was far exceeding the limit (85
ppm) what humans were exposed to. Assessment of
arsenic on the human Y chromosome was undertaken
to uncover its possible effect.
In our study, none of the exposed samples showed any
of the established recombination/deletion events of the
human Y chromosome except a few random microdele-
tions. In our earlier reports in males exposed to natural
background radiation showed a similar pattern but the
occurrence of genetical changes was at a higher frequency
[36]. In our study, deletion was restricted to provirus B
region (see figure 2) which is due to the presence of short
stretches of homologous sequences [36]. These changes
Table 2 The details of SNVs analyzed in the study
Target SNV Primers Enzyme Fragments Allele Present in copies
DAZ Genes SNVs I SA770 Fsp I 709 A 1,2,3
SA771 398+311 B 4
II (sY586) SA446 Mbo I 182 A 1
SA447 122+60 B 2,3,4
III SA772 Taq I 301 A 2
SA773 184+117 B 1,3,4
IV SA774 Alu I 630 A 2
SA775 398+262 B 1,3,4
V (sY587) SA444 Dra I 195+49 A 3,4
SA445 122+73+49 B 1,2
VI SA776 Afl III 431 A 1,2,3
SA777 248+183 B 4
sY581 SA442 Sau3a 189+63 A 1,4
SA443 130+63+59 B 2,3
Blue Amplicons b2_AZFc_SFV SA1237 MnlI 653 A b1, b3, b4
SA1238 452+197 B b2
b3_AZFc_SFV SA1239 XmaJI 510 A b1, b2, b4
SA1240 261+249 B b3
b4_AZFc_SFV SA1241 HphI 630 A b1, b2, b3
SA1242 347+282 B b4
Green Amplicons g1_AZFc_SFV SA1243 Alw261 500 A g2, g3
SA1244 272+224 B g1
g2_AZFc_SFV SA1245 NmuCI 274+180+38 A g2
SA1246 274+137+38+28 B g1, g3
g3_AZFc_SFV SA1247 Alw261 400 A g3
SA1248 251+163 B g1, g2
Gr Amplicons g_AZFc_SFV SA1249 Eco1051 440 A Gr1
SA1250 311+129 B Gr2
GOLGA2LY Genes GOLY/I SA768 HhaI 531 A 1 copy
SA769 289+242 B 1 copy
BPY2 Genes BPY2/I SA766 EcoRV 470 A 2 copies
SA767 289+181 B I copy
TTY4 Genes TTY4/I SA764 HaeIII 541 A 1 copy
SA765 323+218 B 2 copies
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unexposed samples lack such deletions.
Arsenic has been known to cause deletions in cell
lines but in the absence of animal models, it is impossi-
ble to undertake an in-vivo study. Even in the cell lines,
several anomalies were reported but their mechanism
Table 3 Comparative analysis of SNVs located in the
AZFc amplicons between the exposed and unexposed
males.
SNV PROFILE % OF EXPOSED
MALES
% OF UNEXPOSED
MALES
b2_AZFc_SFV A+B 100 100
A 0.0 0.0
B 0.0 0.0
b3_AZFc_SFV A+B 67.6 88.2
B 29.4 11.8
A 2.9 0.0
b4_AZFc_SFV A+B 83.3 91.7
A 16.7 8.3
B 0.0 0.0
g1_AZFc_SFV A+B 83.3 93.8
A 14.6 6.2
B 2.1 0.0
g2_AZFc_SFV A+B 91.2 100
A 5.9 0.0
B 2.9 0.0
g3_AZFc_SFV A+B 87.5 91.6
A 6.25 4.2
B 6.25 4.2
g_AZFc_SFV A+B 88.9 100
A 0.0 0.0
B 11.1 0.0
Figure 4 Result of SNV studies across exposed and normal
samples. Comparative analysis of the results of SNVs present in the
amplicons of AZFc region between the unexposed and exposed
samples. While b2_SFV has both the alleles present in all the
samples (unexposed and exposed) g3_SFv shows a slightly
deviating presence of alleles across the samples. The differences
seem most profound in the b3_SFV between the two sample sets
while in the rest of SFVs show somewhat less variations.
Table 4 Results summary of SNVs analyzed in the genes
in AZFc region with one sample (2k44) showed DAZ4
deletion haplotype.
Gene Allele A only Allele B only
TTY4 - 2k27, 2k28, 2k34, 2k42, 2k45
BPY2 2k12, 2k27, 2k28, 2k35, 2k38 1k4
GOLGA2LY 2k39, 2k40, 1k3, 1k4 2k44, 1k1, 1k8
DAZ SNV I 2K10, 2K18, 2K23, 2K44 -
DAZ SNV III 2K16, 2K17 2K46, 2K47
DAZ SNV VI 2K44 -
Table 5 The primers designed for end point PCR analysis
of DYZ1 repeat region.
Primer Sequence Location Orientation Tm(°
C)
DYZ1A TTTCCTTTCGCTTGCATTCCAT 25-47 5’-3’ 65
DYZ1B TTTTGAGTCCGTTCCATAACAC 1347-
1367
5’-3’ 64
DYZ1C GAGTCCATTCACTTCCAGAACA 3128-
3149
5’-3’ 63
DYZ1D CCATGCCATTTTATTGCGTTGC 1791-
1821
5’-3’ 63
DYZ1E GACTGGAAAGGCTGGGTGTCGA 3380-
3402
3’-5’ 63
DYZ1F TGAAATGGACTGGAAAGGAATG 268-290 3’-5’ 64
DYZ1G TGGAATGGACTGCAATAGAAAG 1566-
1588
3’-5’ 64
DYZ1H TGGAATGGACTCGAACAGAGTG 2097-
2119
3’-5’ 64
Table 6 The primer combinations from table 3 used for
PCR of DYZ1 array and expected amplicons
Sl no Combination Amplicon (bp)
1 DYZ1A & DYZ1E 3378
2 DYZ1A & DYZ1F 266
3 DYZ1A & DYZ1G 1564
4 DYZ1A & DYZ1H 2095
5 DYZ1B & DYZ1E 2056
6 DYZ1B & DYZ1G 242
7 DYZ1B & DYZ1H 773
8 DYZ1C & DYZ1E 275
9 DYZ1 D & DYZ1E 1612
10 DYZ1 D & DYZ1H 329
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genetic targets are yet to be uncovered and any specific
preference for a particular chromosome or sequence is
being probed at. There are multiple reports establishing
the involvement of arsenic in sister chromatid exchange
(SCE) and chromosomal aberrations in cultured cells
[45-47]. None of these or subsequent reports have
focussed on the Y chromosome. However, it may be
noted that the human Y chromosome contains sizable
part of palindromic and repeat sequences which makes
it susceptible to chromosomal rearrangements, deletions
and recombination. In view of the ability of arsenic to
induce such aberrations, Y chromosome provides an
ideal setting for such study. We further plan to study
the integrity of Y chromosome in cell lines when
exposed to arsenic.
T h ep o s s i b l er o l eo fYh a p l o g r o u p sa l s on e e d st ob e
accounted for prior to any conclusions. In present
study, samples were collected from northern India
belonging to Indo-European origins which predomi-
nantly contains R haplogroup with variations in the
DYS marker series [48,49]. Due to the expected
Figure 5 Analysis of DYZ1 region. Gel pictures representing
analysis of DYZ1 repeat array by end point PCR analysis. Ten
different combinations of 8 primers were used for the same (for
details refer to tables 4 and 5) and the array was found to be intact
this approach in all the samples analyzed.
Figure 6 Copy number assessment of DYZ1 per genome. a represents the amplification plot while b and c show the corresponding
standard plot and dissociation curve respectively. d shows the distribution of copy number variation of DYZ1 arrays across the exposed samples
based on real time analysis. As clearly evident, 41% of samples have between 1000-2000 copies while 14% samples had less than thousand
copies. Contrastingly, all the unexposed samples from Delhi had copies ranging from 3800 to 4200.
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Page 9 of 12uniform distribution of this haplogroup in control and
affected sampling regions, we believe deviations
between the two sample-groups cannot be significantly
attributed to haplogroups. We hypothesize that arsenic
in the human body behaves distinctly different as com-
pared to that in established cell lines. Perhaps human
body is lot more efficient to counteract the adverse
effects of arsenic compared to an individual cell or
established cell lines.
SNV analysis showed only one sample with DAZ 4
del haplotype which seems to be a random occur-
rence and the results of ampliconic SNVs seem to be
biased. Of the 7 SNVs in the amplicons of AZFc
region, only one located in b2 amplicon showed iden-
tical pattern of SNV in normal and exposed samples.
The other 6 SNVs showed variation across the sample
sets with maximum one in b3 amplicon (figure 4 and
table 3).
Most startling aspect of our study was the data on the
DYZ1 repeat array. Though the PCR analysis by primers
along its length presented a normal picture in all the
samples, real time and FISH data were found to be
more revealing. The number of copies present in sam-
ples varied from 672 (2k48) to 8576 (2k21) with an
astounding 55% samples having less than 2000 copies
per genome (Figure 6d). The unexposed samples on the
other hand also showed arrays copy number variation
but in much smaller range. Further, variation in signal
intensity within the cell population of same individual
after FISH and absence of signal in ~20% cells in 19
samples seems to be an indicative of the arsenic effects
on DYZ1 array. The selective absence of signals from
certain percentage of cells might be indicative of arsenic
induced aneuploidy. In this context, chromosomal analy-
s i sa tt h es e q u e n c ea n dm a p p i n gl e v e li sr e q u i r e dt o
resolve this issue. Interestingly, the samples which were
showing arsenic skin lesions did not show any apparent
bias towards the aberrations whatsoever. This highlights
our sparingly inconsequent understanding of arsenic in
the human body.
Conclusions
We conclude that arsenic is indeed affecting the human
Y chromosome at a low level and apparently repeat
regions are more prone as evident from our DYZ1
study. Though present study is surely an indicative of
some arsenic manifestations in the body, a large scale
screening of the exposed samples at the genetic level is
required to substantiate the effects of arsenic exposure
on the human system. The potential role of repeat
regions being involved in arsenic induced carcinogenesis
can further be investigated. Absence of a reliable animal
model would continue to dodge the efforts on this line
but sustained efforts would surely yield the mysteries
behind action of arsenic on human body.
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